Stephen D. White, BA, DVM, DACVD, Professor & Chief of Service;
Dr. White is Professor & Chief of Service, Dermatology at the School of Veterinary Medicine at UC Davis. He has worked as a veterinary dermatologist for 3 decades, becoming a Diplomate of the American College of Veterinary Dermatology in 1983.
A graduate of UC Davis, he did his internship and residency at Davis as well. He has held faculty positions at Tufts University School of Veterinary Medicine and Colorado State University College of Veterinary Medicine and Biomedical Sciences, before joining the School of Veterinary Medicine at University of California at Davis as a full Professor in 1998. He has also been staff dermatologist at SPCA Angell Memorial Animal Hospital in Boston, twice a sabbatical professor at the Ecole National Vétérinaire de Nantes, France, and a Clinical Teaching Locum at the Atlantic Veterinary College on Prince Edward Island, Canada.
Dr. White has lectured throughout the USA, Canada, Europe, and Asia. His areas of major interests include cutaneous manifestations of systemic disease, non-steroidal therapy of auto-immune disease, equine dermatology, rabbit/rodent dermatology, and congenital skin disease.
Dr. Corey Saba received her veterinary degree from the University of Luisiana. She is an ACVIM Diplomate (Specialty of Oncology).
Since 2006 she has been an Instructor and Lecturer at University of Georgia. Currently, Dr. Saba is also an Associate Professor of Oncology at University of Georgia.
Dr. Saba is the author of many chapters in several books, including „Withrow and MacEwen's Small Animal Clinical Oncology”, „Consultations in Feline Internal Medicine”, and “Decision Making in Small Animal Oncology”.
She received the clinical research award, sponsored by Pfizer. She was recognized for her contributions toward understanding the use of chemotherapeutic agents in animals, including the specific dosages used to treat neoplasia in small animals. Dr. Saba was also recognized for an evidence-based paper on the use of dexrazoxane for treating doxorubicin extravasation, a rare complication from the administration of chemotherapy.